Institute For Bio Med Sciences is categorized under Commercial Biotechnical Research in Washington, DC and active since 2003.
Institute For Bio Med Sciences was established in 2003, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Richard Southby, Owner at the company’s single location by writing to 2300 I St Nw, Washington, District of Columbia DC 20052 or by phoning (202) 994-2179. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Institute For Bio Med Sciences |
| Contact Person: | Richard Southby, Owner |
| Address: | 2300 I St Nw, Washington, District of Columbia 20052 |
| Phone Number: | (202) 994-2179 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417110 |
| Share This Business: |
Institute For Bio Med Sciences was started in 2003 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Richard Southby, Owner for inquiries that concern Institute For Bio Med Sciences by calling the company number (202) 994-2179, as your correspondence is most welcome. Additionally, the physical location of the single location of Institute For Bio Med Sciences can be found at the coordinates 38.8986,-77.04837 as well as the street address 2300 I St Nw in Washington, District of Columbia 20052.
For its online presence, you may visit Institute For Bio Med Sciences’s website at and engage with its social media outlets through on Twitter and on Facebook.